Octagon Capital Advisors LP
Q1 2025 13F Holdings
- Locationnew york, NY
- Num holdings
35
- Value ($000)
$516,795
- Date Filed05/16/2025
- Form typerestatement
- CIK0001839435
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NUVB/WS NUVATION BIO INC | *W EXP 02/10/202 | 67080N119 | $48.10M | 9 % | 27,330,800 | ||
APLS APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $45.80M | 9 % | 2,094,000 | ||
DNTH DIANTHUS THERAPEUTICS INC | COM | 252828108 | $42.48M | 8 % | 2,341,667 | ||
AVBP ARRIVENT BIOPHARMA INC | COM | 04272N102 | $38.08M | 7 % | 2,059,387 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | $20.90M | 4 % | 3,322,000 | ||
CNTA CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | $20.49M | 4 % | 1,425,000 | ||
GOSS GOSSAMER BIO INC | COM | 38341P102 | $20.18M | 4 % | 18,350,000 | ||
OCUL OCULAR THERAPEUTIX INC | COM | 67576A100 | $17.78M | 3 % | 2,425,000 | ||
MMED MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | $17.66M | 3 % | 3,018,000 | ||
COGT COGENT BIOSCIENCES INC | COM | 19240Q201 | $16.55M | 3 % | 2,763,000 |
Rows Per Page
10
- 10
- 50
- 100